CoChat

Prevention of Diet-Induced Obesity by Phytoecdysteroids 20-Hydroxyecdysone and Calonysterone—Unexpected Modulation of Androgen Balance in Normal and Obese Rats

Open access
Osman, Alaa AM, Laczkó, Dávid, Vágvölgyi, Máté, Tóth, Noémi, Kemény, Kata Kira, Szatmári, Péter, Seres-Bokor, Adrienn, Hunyadi, Attila, Ducza, Eszter · 2026 · Nutrients

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index; 23 of the 44 sources its claims cite were checked for support.

Abstract

Background: Calonysterone (CAL) is a natural derivative of 20-hydroxyecdysone (20E) with enhanced bioactivity on skeletal muscle cells in vitro, but its in vivo physiological actions remain less well characterized. This study aimed to compare the effects of 20E and CAL on metabolic, muscular, and endocrine parameters in normal and obese male rats, with a particular focus on androgen balance. Methods: Male rats were treated with 20E or CAL under normal (ND) or high-fat, high-sugar dietary (HFHSD) conditions for 12 weeks. Body weight, food intake, skeletal and androgen-sensitive muscle mass, and testicular weight were measured. Testicular expression of androgen receptor (Ar) and aromatase (Cyp19a1) mRNA was assessed by RT-PCR. ELISA was used to determine the plasma corticosterone, testosterone and ERβ level in testes. Results: 20E and CAL prevented HFHSD-induced weight gain and skeletal muscle atrophy. CAL uniquely preserved testicular and levator ani muscle mass in obese rats. CAL increased the expression of Cyp19a1 and ERβ in testicles. Decreased Ar mRNA expression was regulated in 20E- and CAL-treated obese animals. While 20E treatment significantly reduced plasma testosterone levels in the normal diet group compared to controls, both 20E and CAL interventions elicited significant reductions in the obese group relative to both the ND and HFHSD groups. HFHSD-induced increase in plasma corticosterone levels was normalized by 20E or CAL treatment. Conclusions: 20E and CAL exhibit beneficial metabolic and anabolic effects by preventing HFHSD-induced obesity and consequential muscle atrophy. CAL counteracts obesity-induced testicular atrophy in terms of tissue mass. Based on our results, we hypothesized that CAL enhances testicular aromatase levels, which may lead to increased compensatory androgen receptor mRNA expression and increased ERβ levels. These complex, not yet fully understood results underscore the need for caution in the use of phytoecdysteroids as dietary supplements.

Overview

CoChat Summary

TL;DR

In 12-week studies in male Sprague–Dawley rats, both 20-hydroxyecdysone (20E) and calonysterone (CAL) prevented high-fat, high-sugar diet (HFHSD)-induced weight gain and skeletal muscle atrophy. CAL had the more distinctive endocrine/reproductive profile: it preserved testicular and levator ani mass in obese rats, increased testicular Cyp19a1 and ERβ mRNA, and also raised Ar mRNA in normal-diet rats.

Key findings

  • HFHSD increased body weight versus normal diet, and daily treatment with 20E or CAL for 12 weeks prevented the HFHSD weight-gain effect; CAL also significantly decreased body weight in the normal-diet control group.
  • HFHSD reduced testicular mass and musculus levator ani mass; 20E did not prevent this, whereas CAL normalized both, increasing testicular weight by 21.11% and levator ani weight by 43.94% versus untreated HFHSD.
  • Both 20E and CAL protected against HFHSD-related shrinkage of tibialis anterior and soleus muscles; in the results section, CAL and diet interacted significantly for body weight, total caloric consumption, testicular weight, levator ani, tibialis anterior, soleus, and ERβ, with reported p-values including p < 0.0001 for total caloric consumption and p = 0.0126 for body weight.
  • Endocrine effects differed by compound and diet: CAL increased testicular Cyp19a1 mRNA in normal-diet rats and increased ERβ in obese testicular tissue; both 20E and CAL increased Ar mRNA in HFHSD testicular tissue, while plasma testosterone decreased in treated obese rats, and HFHSD-induced corticosterone elevation was normalized by both treatments.

Methods

  • Male Sprague–Dawley rats were randomized into 6 groups (n = 36 total; n = 6 per group): HFHSD, HFHSD+20E, HFHSD+CAL, ND, ND+20E, ND+CAL; treatment was 10 mg/kg/day by oral gavage for 12 weeks.
  • Outcomes included weekly body weight and food intake, terminal testicular and muscle weights (levator ani, tibialis anterior, soleus), testicular Ar and Cyp19a1 mRNA by RT-PCR, and plasma/testicular testosterone, corticosterone, and ERβ by ELISA.
  • Data were analyzed with Shapiro–Wilk, then two-way ANOVA with Tukey’s post hoc test; significance was set at p < 0.05.

Limitations

  • The paper states that findings are from rats, include only male subjects, do not address safety of long-term chronic administration in other tissues, do not compare different doses or rodent–human bioavailability, and lack protein-level and hormone-panel measures such as AR, ERβ, aromatase activity, LH, and FSH.
  • The paper also states it did not apply a global correction for multiple testing across the many outcome families; it warns that some significant findings may be potential false positives.
  • Evident from the text: the study is limited to a single dose and a 12-week exposure window, so dose–response and longer-term reproductive outcomes are not directly tested.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/nu18122023

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Animal experiment flowchart. Rat feeding and treatments continued for a duration of 12 weeks from the age of 6 weeks. HFHSD: high-fat, high-sugar diet; ND: normal diet; 20E: 20-hydroxyecdysone; CAL: calonysterone; ↑ first day of week.
Figure 1 Animal experiment flowchart. Rat feeding and treatments continued for a duration of 12 weeks from the age of 6 weeks. HFHSD: high-fat, high-sugar diet; ND: normal diet; 20E: 20-hydroxyecdysone; CAL: calonysterone; ↑ first day of week.CC BY · PubMed Central
Figure 2 Changes in body weight in different groups until the end of the study (A) and caloric consumption (B) during the study. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; *: p < 0.05; ***: p < 0.001 compared to the normal diet group (ND). #: p < 0.05; ###: p < 0.001 compared to the HFHSD group.
Figure 2 Changes in body weight in different groups until the end of the study (A) and caloric consumption (B) during the study. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; *: p < 0.05; ***: p < 0.001 compared to the normal diet group (ND). #: p < 0.05; ###: p < 0.001 compared to the HFHSD group.CC BY · PubMed Central
Figure 3 Changes in testicle (A) and musculus levator ani (B) weight per 100 g body weight. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; *: p < 0.05 compared to the normal diet (ND). #: p < 0.05; ##: p < 0.01 compared to the HFHSD group.
Figure 3 Changes in testicle (A) and musculus levator ani (B) weight per 100 g body weight. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; *: p < 0.05 compared to the normal diet (ND). #: p < 0.05; ##: p < 0.01 compared to the HFHSD group.CC BY · PubMed Central
Figure 4 Changes in rat tibialis anterior (A) and musculus soleus (B) weight per 100 g body weight. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; ***: p < 0.001 compared to the control (ND). ##: p < 0.01; ###: p < 0.001 compared to the HFHSD group.
Figure 4 Changes in rat tibialis anterior (A) and musculus soleus (B) weight per 100 g body weight. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; ***: p < 0.001 compared to the control (ND). ##: p < 0.01; ###: p < 0.001 compared to the HFHSD group.CC BY · PubMed Central
Figure 5 Alterations in aromatase mRNA expression in the rat testicular tissues. ND: control (standard diet); HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; ***: p < 0.001 compared to the normal diet control (ND). #: p < 0.05 compared to the HFHSD group.
Figure 5 Alterations in aromatase mRNA expression in the rat testicular tissues. ND: control (standard diet); HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; ***: p < 0.001 compared to the normal diet control (ND). #: p < 0.05 compared to the HFHSD group.CC BY · PubMed Central
Figure 6 Alterations in Ar mRNA expression in testicular tissues. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; *: p < 0.05; compared to the ND. #: p < 0.05; compared to the HFHSD group.
Figure 6 Alterations in Ar mRNA expression in testicular tissues. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; *: p < 0.05; compared to the ND. #: p < 0.05; compared to the HFHSD group.CC BY · PubMed Central
Figure 7 Alterations in testosterone level in the rat plasma. ND: control (normal diet); HFHSD: high fat high sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; ***: p < 0.001 compared to the normal diet (ND). #: p < 0.05; ##: p < 0.01 compared to the HFHSD group.
Figure 7 Alterations in testosterone level in the rat plasma. ND: control (normal diet); HFHSD: high fat high sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; ***: p < 0.001 compared to the normal diet (ND). #: p < 0.05; ##: p < 0.01 compared to the HFHSD group.CC BY · PubMed Central
Figure 8 Changes in ERβ concentration in rat testes in different diet groups. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; *: p < 0.05; compared to the control (ND). #: p < 0.05; compared to the HFHSD group.
Figure 8 Changes in ERβ concentration in rat testes in different diet groups. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; *: p < 0.05; compared to the control (ND). #: p < 0.05; compared to the HFHSD group.CC BY · PubMed Central
Figure 9 Changes in plasma corticosterone levels in rats in different diet groups. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; **: p < 0.01; compared to the normal diet (ND). #: p < 0.05; compared to the HFHSD group.
Figure 9 Changes in plasma corticosterone levels in rats in different diet groups. ND: normal diet; HFHSD: high-fat, high-sugar diet; 20E: 20-hydroxyecdysone; CAL: calonysterone treatments; ns: p > 0.05; **: p < 0.01; compared to the normal diet (ND). #: p < 0.05; compared to the HFHSD group.CC BY · PubMed Central

Verification

Claims the paper makes

17 Valid · 2 Not valid · 14 Not checked · 82 Own results and interpretations

70 more claims

Create a free account to see all 115 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 27
  • It may state two separate claims as one. 23
  • The quote only partly states this claim. 1

Create a free account to see these claims.

Citations

Cites

Research works printed but not linked: 2

  1. Chu, 2025, LC-MS/MS Fingerprinting Analysis of Cyanotis arachnoidea Extracts: Process-Related Artifacts in Anabolic Food Supplements, ACS Omega, 10, 18605
  2. Carreau, 2004, The promoter(s) of the aromatase gene in male testicular cells, Reprod. Biol., 4, 23

Metadata

Authors
Osman, A. A., Laczkó, D., Vágvölgyi, M., Tóth, N., Kemény, K. K., Szatmári, P., Seres-Bokor, A., Hunyadi, A., & Ducza, E.
Affiliations
  • University of Szeged (HU)
  • Department of Pharmacodynamics and Biopharmacy, Faculty of Pharmacy, University of Szeged, Eötvös u. 6, H-6720 Szeged, Hungary
Corresponding author
Ducza, Eszter
Venue
Nutrients
Publisher
MDPI AG
Published
2026-06-21
Volume
18
Issue
12
Pages
2023
ISSN
2072-6643 (ISSN-L)
OpenAlex
W7165627705
Cited by
0
References
53
FWCI
0.00
Type
journal article
Language
en
Open access
Locations
  • Nutrients (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, cc-by)
Funders
  • National Research, Development and Innovation Office (NKFI-FK19-132499, K-146359, 2022-1.2.6-TÉT-IPARI-TR-2022-00024)
  • Ministry of Innovation and Technology of Hungary (TKP2021-EGA-32)
  • National Research, Development and Innovation Fund (TKP2021-EGA)
  • Cooperative Doctoral Program (1005968)
  • University of Szeged (8608)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
phytoecdysteroids, 20-hydroxyecdysone, diet-induced obesity, high-fat high-sugar diet, androgen receptor, aromatase, estrogen receptor beta, testicular atrophy, skeletal muscle atrophy, levator ani muscle, testosterone, corticosterone, dietary supplements
MeSH terms
Androgens, Animals, Aromatase, Corticosterone, Ecdysterone, Male, Obesity, Receptors, Androgen, Testis, Testosterone, Rats, Sprague-Dawley, Muscle, Skeletal, Estrogen Receptor beta, Rats, Diet, High-Fat

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.